Joseph R. Laforet Jr.
Research Subjects
Joseph R. Laforet Jr. has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Chinmay S. Potnis
Department of Chemistry, University of Louisville, Louisville, USA
1 shared publication - Daniel Reker
Duke University
1 shared publication - Hrshita Gowda
Department of Biomedical Engineering
1 shared publication - Lauren A. Onweller
Department of Biomedical Engineering
1 shared publication - Rebeca T. Stiepel
Department of Biomedical Engineering
1 shared publication - Yan Xiang
Duke University
1 shared publication
Latest Publications
- Open Access
- 6 April 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Physics-informed design of drug-excipient nanoparticles via free energy calculation and yoked deep learning
The discovery of self-assembling molecular systems is often constrained by the high computational cost of physics-based simulations and the limited generalizability of data-driven models trained on experimental datasets. This limits our ability to efficiently navigate massive design spaces. Here, we introduce a physics-informed discovery framework that integrates free-energy calculations with sequential-pool active learning and adaptive yoked deep learning to effectively navigate vast chemical coassembly spaces. Using pairwise free energy as a physically grounded descriptor of co-assembly propensity and excipient net charge as a proxy for interfacial stabilization, our approach predicts nanoparticle-forming drug–excipient combinations without relying on experimental data for model training. Our sequential-pool yoked deep learning strategy utilizes adaptive machine learning to reduce the number of expensive simulations required while maintaining predictive accuracy, enabling screening of 18 million molecular pairs. Prospective validations identified 24 drug nanoparticles using eight previously unknown stabilizing molecules. The new nanoparticles exhibit ultra-high drug loading, effectively improve the aqueous solubility of drugs, and maintain in vitro drug efficacy. Together, this work establishes a generalizable framework coupling molecular simulations and yoked deep learning to accelerate discovery in self-assembling molecular systems.
- 6 April 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessPhysics-informed design of drug-excipient nanoparticles via free energy calculation and yoked deep learning
The discovery of self-assembling molecular systems is often constrained by the high computational cost of physics-based simulations and the limited generalizability of data-driven models trained on experimental datasets. This limits our ability to efficiently navigate massive design spaces. Here, we introduce a physics-informed discovery framework that integrates free-energy calculations with sequential-pool active learning and adaptive yoked deep learning to effectively navigate vast chemical coassembly spaces. Using pairwise free energy as a physically grounded descriptor of co-assembly propensity and excipient net charge as a proxy for interfacial stabilization, our approach predicts nanoparticle-forming drug–excipient combinations without relying on experimental data for model training. Our sequential-pool yoked deep learning strategy utilizes adaptive machine learning to reduce the number of expensive simulations required while maintaining predictive accuracy, enabling screening of 18 million molecular pairs. Prospective validations identified 24 drug nanoparticles using eight previously unknown stabilizing molecules. The new nanoparticles exhibit ultra-high drug loading, effectively improve the aqueous solubility of drugs, and maintain in vitro drug efficacy. Together, this work establishes a generalizable framework coupling molecular simulations and yoked deep learning to accelerate discovery in self-assembling molecular systems.